Seller comparison · US self-pay prices

Ivim Health vs MEDVi: GLP-1 Prices Compared

Ivim Health and MEDVi both sell compounded semaglutide injection and compounded tirzepatide injection. Compounded semaglutide injection: not ranked against each other, because one is a medication-plus-membership total and the other a single advertised price: Ivim Health advertises $224.99/mo ($150 medication + $74.99 monthly membership/provider fee), MEDVi $299/mo. Compounded tirzepatide injection: not ranked against each other, because one is a medication-plus-membership total and the other a single advertised price: Ivim Health advertises $324.99/mo ($250 medication + $74.99 monthly membership/provider fee), MEDVi $299/mo. Only Ivim Health sells Zepbound injection, Wegovy pill, and Foundayo pill here. What each sells here: Ivim Health, FDA-approved brand-name GLP-1s and compounded versions; MEDVi, compounded GLP-1s only. Compounded GLP-1s are not FDA-approved. Prices checked Oct 17, 2026.

Every cash quote was checked on or after . Each quote shows its own check date. A quoted price is not a recommendation of a seller, a product or a dose. How we source prices

Same product

What Ivim Health and MEDVi charge for the same medication

Entry prices first, then the published top-dose price where either seller states one. Each price links the seller's own page.

Compounded semaglutide injection

Entry price: not ranked against each other, because one is a medication-plus-membership total and the other a single advertised price: Ivim Health advertises $224.99/mo ($150 medication + $74.99 monthly membership/provider fee), MEDVi $299/mo.

IHIvim Health

Advertised entry price

$224.99/mo

Calculated: $150 medication + $74.99 ongoing membership/provider fee. Charges billed separately.

Separate billing cycles; excluded from cost ranking.

Checked

Compounded semaglutide via Ivim Health

Ivim Health · Sourced provider quote

Price conditions

Calculated: $150 medication + $74.99 ongoing membership/provider fee

1-month program. On 12 months the medication is $780 ($65 a month) plus $899.88 of membership, $1,679.88 in all; compounded programs are paid upfront and the membership runs for the whole plan. Other Ivim pages show $75, $140 or $149 a month for semaglutide. Compounded; not FDA-approved.

MMEDVi

Advertised entry price

$299/mo

Supply period unverified; excluded from cost ranking.

Checked

Compounded semaglutide via MEDVi

MEDVi · Sourced provider quote

refill price after a $179 first month; physician review, personalized plan, guidance and the medication included; no contract

Price conditions

refill price after a $179 first month; physician review, personalized plan, guidance and the medication included; no contract

Weekly injection. Another MEDVi landing page shows semaglutide at $116 a month in one place and $166 a month in its FAQ. MEDVi also sells a daily GLP-1 tablet from $249 without naming the drug. Compounded; not FDA-approved.

Compounded tirzepatide injection

Entry price: not ranked against each other, because one is a medication-plus-membership total and the other a single advertised price: Ivim Health advertises $324.99/mo ($250 medication + $74.99 monthly membership/provider fee), MEDVi $299/mo.

IHIvim Health

Advertised entry price

$324.99/mo

Calculated: $250 medication + $74.99 ongoing membership/provider fee. Charges billed separately.

Separate billing cycles; excluded from cost ranking.

Checked

Compounded tirzepatide via Ivim Health

Ivim Health · Sourced provider quote

Price conditions

Calculated: $250 medication + $74.99 ongoing membership/provider fee

1-month program. On 12 months the medication is $1,400 (about $117 a month) plus $899.88 of membership, $2,299.88 in all, paid upfront. Other Ivim pages show $133 or $192 a month for tirzepatide. Compounded; not FDA-approved.

MMEDVi

Advertised entry price

$299/mo

Supply period unverified; excluded from cost ranking.

Checked

Compounded tirzepatide via MEDVi

MEDVi · Sourced provider quote

monthly plan, a 4-week supply, $199 the first month with a code the page applies itself; $193/mo on 12 weeks, $183 on 24 weeks, $166 on 48 weeks; same price at every dose; auto-renewing subscription

Price conditions

monthly plan, a 4-week supply, $199 the first month with a code the page applies itself; $193/mo on 12 weeks, $183 on 24 weeks, $166 on 48 weeks; same price at every dose; auto-renewing subscription

Weekly injection. Another MEDVi landing page shows tirzepatide at $166 a month, and $199 a month in its FAQ. Multi-month packages are not refunded for unused months. Compounded; not FDA-approved.

Sold by one of them

What only one of them sells

IHIvim Health
  • Zepbound injection

    Advertised entry price

    $373.99/mo

    Calculated: $299 medication + $74.99 ongoing membership/provider fee. Charges billed separately.

    Separate billing cycles; excluded from cost ranking.

    Checked

    Zepbound KwikPen via Ivim Health

    Ivim Health · Sourced provider quote

    Price conditions

    Calculated: $299 medication + $74.99 ongoing membership/provider fee

    A 1-month supply at 2.5 mg; the medication prices match Eli Lilly's own self-pay prices. FDA-approved product.

    Published maintenance dose

    $523.99/mo

    Calculated: $449 medication + $74.99 ongoing membership/provider fee. Charges billed separately.

    Separate billing cycles; excluded from cost ranking.

    Checked

    At 15 mg

    Zepbound KwikPen via Ivim Health

    Ivim Health · Sourced provider quote

    Price conditions

    Calculated: $449 medication + $74.99 ongoing membership/provider fee

    A 1-month supply at 2.5 mg; the medication prices match Eli Lilly's own self-pay prices. FDA-approved product.

    Ivim lists $449 of medication at 7.5 to 15 mg, for vials and KwikPens alike.

  • Wegovy pill

    Advertised entry price

    $223.99/mo

    Calculated: $149 medication + $74.99 ongoing membership/provider fee. Charges billed separately.

    Separate billing cycles; excluded from cost ranking.

    Checked

    Wegovy pill via Ivim Health

    Ivim Health · Sourced provider quote

    Price conditions

    Calculated: $149 medication + $74.99 ongoing membership/provider fee

    A 1-month supply at 1.5 mg; $199 of medication at 4 mg on this product line, though another Ivim page lists 4 mg at $149. FDA-approved product.

    Published maintenance dose

    $373.99/mo

    Calculated: $299 medication + $74.99 ongoing membership/provider fee. Charges billed separately.

    Separate billing cycles; excluded from cost ranking.

    Checked

    At 25 mg

    Wegovy pill via Ivim Health

    Ivim Health · Sourced provider quote

    Price conditions

    Calculated: $299 medication + $74.99 ongoing membership/provider fee

    A 1-month supply at 1.5 mg; $199 of medication at 4 mg on this product line, though another Ivim page lists 4 mg at $149. FDA-approved product.

  • Foundayo pill

    Advertised entry price

    $223.99/mo

    Calculated: $149 medication + $74.99 ongoing membership/provider fee. Charges billed separately.

    Separate billing cycles; excluded from cost ranking.

    Checked

    Foundayo via Ivim Health

    Ivim Health · Sourced provider quote

    Price conditions

    Calculated: $149 medication + $74.99 ongoing membership/provider fee

    A 1-month supply at 0.8 mg ($149 of medication at 2.5 mg too). FDA-approved product.

    Published maintenance dose

    $373.99/mo

    Calculated: $299 medication + $74.99 ongoing membership/provider fee. Charges billed separately.

    Separate billing cycles; excluded from cost ranking.

    Checked

    At 17.2 mg

    Foundayo via Ivim Health

    Ivim Health · Sourced provider quote

    Price conditions

    Calculated: $299 medication + $74.99 ongoing membership/provider fee

    A 1-month supply at 0.8 mg ($149 of medication at 2.5 mg too). FDA-approved product.

    $299 of medication from 9 mg up; $199 at 5.5 mg.

MMEDVi

Everything MEDVi sells here is also sold by the other seller (above).

Compounded GLP-1s are not FDA-approved. Compounded drugs are not FDA-approved: the FDA does not review them for safety, effectiveness or quality before they are marketed. FDA: concerns with unapproved GLP-1 drugs used for weight loss

Every sourced offer

All Ivim Health and MEDVi offers

Both sellers' quotes in one table, lowest 30-day cost first where the seller states its supply.

7 offers · US self-pay

Read prices in context. Compare the same product, dose, and payment terms. A prepaid monthly rate is not a monthly payment. Cost order uses current, recently checked quotes with documented supply periods, converted to 30 days. Other prices are unranked references. Dose changes, introductory terms and added fees affect what you pay.

Missing prices are not estimated. A listed maintenance dose is not a dosing recommendation.

The FDA declared the tirzepatide (December 2024) and semaglutide (February 2025) shortages resolved, ending the exemption that let pharmacies mass-produce compounded copies, and the 503A/503B enforcement-discretion grace periods ended in 2025. The FDA is now actively enforcing (warning letters and takedowns, including a September 2026 warning letter to Empower Pharmacy, a large compounder, over products it called essentially copies of approved semaglutide and tirzepatide), and in 2026 proposed permanently excluding semaglutide, tirzepatide, and liraglutide from the 503B bulks list (the public comment period, extended 30 days, closed July 30, 2026; a final decision is pending). Liraglutide is different: it is still on the FDA drug shortage list (brand Victoza and Saxenda in limited supply, generics available, as of September 2026). Compounded GLP-1s are not FDA-approved and are now generally limited to narrow, patient-specific 503A prescriptions, so broad low-cost availability has largely wound down. They also carry safety risks the branded products do not: FDA adverse-event reports, at least one sterility recall (ProRx, October 2025), and counterfeit product found in the US supply chain, so a low price is not a low-risk signal. Prices and availability below may lag these changes; confirm current terms with the provider.

Questions

Ivim Health vs MEDVi: common questions

Is Ivim Health or MEDVi cheaper for GLP-1 medication?

Compounded semaglutide injection: not ranked against each other, because one is a medication-plus-membership total and the other a single advertised price: Ivim Health advertises $224.99/mo ($150 medication + $74.99 monthly membership/provider fee), MEDVi $299/mo. Compounded tirzepatide injection: not ranked against each other, because one is a medication-plus-membership total and the other a single advertised price: Ivim Health advertises $324.99/mo ($250 medication + $74.99 monthly membership/provider fee), MEDVi $299/mo. Only Ivim Health: Zepbound injection $373.99/mo ($299 medication + $74.99 monthly membership/provider fee); Wegovy pill $223.99/mo ($149 medication + $74.99 monthly membership/provider fee); Foundayo pill $223.99/mo ($149 medication + $74.99 monthly membership/provider fee). Prices are the sellers' own advertised self-pay prices, with the conditions listed beside each.

Do Ivim Health and MEDVi sell FDA-approved GLP-1s or compounded versions?

What each sells here: Ivim Health, FDA-approved brand-name GLP-1s and compounded versions; MEDVi, compounded GLP-1s only. Compounded GLP-1s are not FDA-approved. The FDA does not review compounded drugs for safety, effectiveness or quality.

What do Ivim Health and MEDVi prices include?

Ivim Health, compounded semaglutide injection: $224.99/mo ($150 medication + $74.99 monthly membership/provider fee). MEDVi, compounded semaglutide injection: $299/mo, refill price after a $179 first month; physician review, personalized plan, guidance and the medication included; no contract. Ivim Health, compounded tirzepatide injection: $324.99/mo ($250 medication + $74.99 monthly membership/provider fee). MEDVi, compounded tirzepatide injection: $299/mo, monthly plan, a 4-week supply, $199 the first month with a code the page applies itself; $193/mo on 12 weeks, $183 on 24 weeks, $166 on 48 weeks; same price at every dose; auto-renewing subscription. Ivim Health, Zepbound injection: $373.99/mo ($299 medication + $74.99 monthly membership/provider fee). Ivim Health, Wegovy pill: $223.99/mo ($149 medication + $74.99 monthly membership/provider fee). Ivim Health, Foundayo pill: $223.99/mo ($149 medication + $74.99 monthly membership/provider fee).

When were Ivim Health and MEDVi prices last checked?

Prices checked Oct 17, 2026. Each quote links the seller's own page it was read from. A quote not rechecked within 21 days is kept as a dated reference and is no longer stated as a current price.

GLPcompare is an informational data platform, not a medical provider or pharmacy. Nothing here is medical advice, a diagnosis, or a recommendation to start, stop, or change any treatment. Data is aggregated from public sources and can be incomplete or out of date. Always confirm with a licensed clinician and the current FDA label.